Dewpoint therapeutics frankfurt
WebMay 25, 2024 · Dewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. ... Dresden and Frankfurt to translate condensate biology into ...
Dewpoint therapeutics frankfurt
Did you know?
WebApr 13, 2024 · Dewpoint Therapeutics translates condensate biology into much-needed medicines. Biomolecular condensates are transforming our understanding of biology, and our highly collaborative team is at the forefront of efforts to harness this shift for drug discovery. Together, we are leveraging a transformative shift in the understanding of … WebDewpoint scientists work in Boston, Dresden, and Frankfurt to translate condensate biology into treatments for the toughest diseases. Dewpoint Therapeutics 6,096 followers on LinkedIn.
WebDewpoint scientists are working in Boston, MA, and Dresden and Frankfurt, Germany, to translate condensate biology into treatments for the toughest diseases. Dewpoint Therapeutics is an equal opportunity employer committed to the principles of non-discrimination in the workplace. WebDewpoint-Wissenschaftler arbeiten in Boston, Dresden und Frankfurt daran, Kondensatbiologie in Therapien für schwer zu behandelnde Krankheiten umzusetzen. …
WebDewpoint Therapeutics 6,467 followers on LinkedIn. Dewpoint is translating condensate biology into medicine. Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of … WebDewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. Its technology uses machine-learning-based image analysis tools for visualizing condensates and offers an engine for genetically linked condensatopathy which is a collection of engineered cell lines with trackable …
WebDewpoint scientists are working in Boston, MA, and Dresden and Frankfurt, Germany, to translate condensate biology into treatments for the toughest diseases. Dewpoint Therapeutics is an equal opportunity employer committed to the principles of non-discrimination in the workplace.
WebJun 16, 2024 · BOSTON, June 16, 2024 /PRNewswire/ -- Dewpoint Therapeutics, the biomolecular condensates company, today announced the appointment of Michael Wagner, Ph.D., as Senior Vice President of Chemistry ... jeep dealer plymouth miWebMar 20, 2024 · Dewpoint Therapeutics applies the latest findings on biomolecular condensates to drug research, for example in the field of cancer. The company employs scientists at its sites in Boston, Dresden, and Frankfurt. Dewpoint Therapeutics is using the USD 150 million raised in a Series C to advance several pipeline programmes to IND … owner occupied commercial real estate lendingWebJul 21, 2024 · Dewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. ... Dresden and Frankfurt to translate condensate biology into ... jeep dealer puyallup waWebDewpoint scientists work in Boston, Dresden, and Frankfurt to translate condensate biology into treatments for the toughest diseases. ... Dewpoint Therapeutics 4,402 followers on LinkedIn ... jeep dealer pleasant hills paWebChief Scientific Officer. Apr 2024 - Present2 years 1 month. Boston, Massachusetts, United States. I am part of an international Research … jeep dealer rapid city south dakotaWebOur Frankfurt Labs Our Frankfurt Labs Our Frankfurt Office Dewpoint is an international company with research teams in Boston, Frankfurt and Dresden. Our offices, recognized as “award winning workspaces and labs” help to make Dewpoint a vibrant and exciting place to work. ... Dewpoint Therapeutics 451 D Street, Suite 104 Boston, MA 02210 USA jeep dealer red wing mnWebMar 22, 2024 · Dewpoint scientists work in Boston , Dresden and Frankfurt to translate condensate biology into medicine for diseases previously considered untreatable. Learn more at Dewpointx ... Contacts Media Jeanette Bressi VP, Head, Communications & PR Dewpoint Therapeutics +1 609-439-3997 [email protected] Investors ... owner occupied commercial real estate loans